Properties (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
dimethyl_fumarate
|
| gptkbp:brand |
gptkb:Tecfidera
|
| gptkbp:chemicalFormula |
C10H11O4S
|
| gptkbp:clinicalTrials |
Phase 3
|
| gptkbp:compatibleWith |
approximately 50%
|
| gptkbp:contraindication |
hypersensitivity to dimethyl fumarate
|
| gptkbp:date |
March 2013
|
| gptkbp:dosageForm |
capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tecfidera
|
| gptkbp:lastProduced |
gptkb:FDA
|
| gptkbp:maintenanceFee |
240 mg
|
| gptkbp:manufacturer |
gptkb:Biogen
|
| gptkbp:marketedAs |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:operates_in |
L04AA31
|
| gptkbp:route |
oral
|
| gptkbp:sells |
gptkb:Tecfidera
|
| gptkbp:sideEffect |
liver enzyme elevation
flushing gastrointestinal events |
| gptkbp:startsAt |
120 mg
|
| gptkbp:triggerType |
anti-inflammatory
neuroprotective |
| gptkbp:usedFor |
multiple sclerosis
|